Daniel Gaudet
Daniel Gaudet
ecogene21 Biocluster and dept of Medicine Université de Montréal
Adresse e-mail validée de umontreal.ca
TitreCitée parAnnée
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
D Altshuler, JN Hirschhorn, M Klannemark, CM Lindgren, MC Vohl, ...
Nature genetics 26 (1), 76, 2000
20612000
Simvastatin with or without ezetimibe in familial hypercholesterolemia
JJP Kastelein, F Akdim, ESG Stroes, AH Zwinderman, ML Bots, ...
New England Journal of Medicine 358 (14), 1431-1443, 2008
15112008
Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?
I Lemieux, A Pascot, C Couillard, B Lamarche, A Tchernof, N Alméras, ...
Circulation 102 (2), 179-184, 2000
11252000
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease
JD Rioux, MJ Daly, MS Silverberg, K Lindblad, H Steinhart, Z Cohen, ...
Nature genetics 29 (2), 223, 2001
8862001
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised …
FJ Raal, RD Santos, DJ Blom, AD Marais, MJ Charng, WC Cromwell, ...
The Lancet 375 (9719), 998-1006, 2010
7512010
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on …
EA Stein, D Gipe, J Bergeron, D Gaudet, R Weiss, R Dufour, R Wu, ...
The Lancet 380 (9836), 29-36, 2012
5662012
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
FJ Raal, EA Stein, R Dufour, T Turner, F Civeira, L Burgess, G Langslet, ...
The Lancet 385 (9965), 331-340, 2015
5462015
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
M Cuchel, EA Meagher, H du Toit Theron, DJ Blom, AD Marais, ...
the Lancet 381 (9860), 40-46, 2013
5342013
Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia
C Gagné, D Gaudet, E Bruckert
Circulation 105 (21), 2469-2475, 2002
4902002
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
AC Villani, M Lemire, G Fortin, E Louis, MS Silverberg, C Collette, N Baba, ...
Nature genetics 41 (1), 71, 2009
4102009
Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region
JC Florez, N Burtt, PIW De Bakker, P Almgren, T Tuomi, J Holmkvist, ...
Diabetes 53 (5), 1360-1368, 2004
3162004
Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia
D Gaudet, VJ Alexander, BF Baker, D Brisson, K Tremblay, W Singleton, ...
New England Journal of Medicine 373 (5), 438-447, 2015
2852015
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
D Gaudet, J Méthot, S Déry, D Brisson, C Essiembre, G Tremblay, ...
Gene therapy 20 (4), 361, 2013
2832013
Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess …
EA Stein, R Dufour, C Gagne, D Gaudet, C East, JM Donovan, W Chin, ...
Circulation 126 (19), 2283-2292, 2012
2672012
Targeting APOC3 in the familial chylomicronemia syndrome
D Gaudet, D Brisson, K Tremblay, VJ Alexander, W Singleton, SG Hughes, ...
New England Journal of Medicine 371 (23), 2200-2206, 2014
2512014
Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes
W Winckler, MN Weedon, RR Graham, SA McCarroll, S Purcell, ...
Diabetes 56 (3), 685-693, 2007
2252007
Molecular scanning of the human PPARα gene: association of the L162V mutation with hyperapobetalipoproteinemia
MC Vohl, P Lepage, D Gaudet, CG Brewer, C Bétard, P Perron, G Houde, ...
Journal of Lipid Research 41 (6), 945-952, 2000
2222000
5′ flanking variants of resistin are associated with obesity
JC Engert, MC Vohl, SM Williams, P Lepage, JC Loredo-Osti, J Faith, ...
Diabetes 51 (5), 1629-1634, 2002
2142002
Genomewide linkage analysis of stature in multiple populations reveals several regions with evidence of linkage to adult height
JN Hirschhorn, CM Lindgren, MJ Daly, A Kirby, SF Schaffner, NP Burtt, ...
The American Journal of Human Genetics 69 (1), 106-116, 2001
2012001
Alirocumab as add-on to atorvastatin versus other lipid treatment strategies: ODYSSEY OPTIONS I randomized trial
H Bays, D Gaudet, R Weiss, JL Ruiz, GF Watts, I Gouni-Berthold, ...
The Journal of Clinical Endocrinology & Metabolism 100 (8), 3140-3148, 2015
1902015
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20